These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 37201414

  • 1. β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice.
    Li HR, Liu Q, Zhu CL, Sun XY, Sun CY, Yu CM, Li P, Deng XM, Wang JF.
    Redox Biol; 2023 Jul; 63():102745. PubMed ID: 37201414
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons.
    Chandrasekaran K, Choi J, Arvas MI, Salimian M, Singh S, Xu S, Gullapalli RP, Kristian T, Russell JW.
    Int J Mol Sci; 2020 May 26; 21(11):. PubMed ID: 32466541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nicotinamide mononucleotide pretreatment improves long-term isoflurane anesthesia-induced cognitive impairment in mice.
    Xu J, Chen X, Liu S, Wei Z, Xu M, Jiang L, Han X, Peng L, Gu X, Xia T.
    Behav Brain Res; 2024 Feb 26; 458():114738. PubMed ID: 37931707
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment.
    Chen X, Amorim JA, Moustafa GA, Lee JJ, Yu Z, Ishihara K, Iesato Y, Barbisan P, Ueta T, Togka KA, Lu L, Sinclair DA, Vavvas DG.
    Aging (Albany NY); 2020 Dec 29; 12(24):24504-24521. PubMed ID: 33373320
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation.
    Wu K, Li B, Lin Q, Xu W, Zuo W, Li J, Liu N, Tu T, Zhang B, Xiao Y, Liu Q.
    Life Sci; 2021 Jun 01; 274():119299. PubMed ID: 33675899
    [Abstract] [Full Text] [Related]

  • 10. Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis.
    Cao T, Ni R, Ding W, Ji X, Fan GC, Zhang Z, Peng T.
    J Transl Med; 2023 Dec 06; 21(1):883. PubMed ID: 38057866
    [Abstract] [Full Text] [Related]

  • 11. Nicotinamide mononucleotide attenuates HIF-1α activation and fibrosis in hypoxic adipose tissue via NAD+/SIRT1 axis.
    Wu K, Li B, Ma Y, Tu T, Lin Q, Zhu J, Zhou Y, Liu N, Liu Q.
    Front Endocrinol (Lausanne); 2023 Dec 06; 14():1099134. PubMed ID: 36777361
    [Abstract] [Full Text] [Related]

  • 12. Nicotinamide Mononucleotide (NMN) Ameliorates Free Fatty Acid-Induced Pancreatic β-Cell Dysfunction via the NAD+/AMPK/SIRT1/HIF-1α Pathway.
    Wang Y, Liu S, Ying L, Zhang K, Li H, Liang N, Xiao L, Luo G.
    Int J Mol Sci; 2024 Sep 30; 25(19):. PubMed ID: 39408861
    [Abstract] [Full Text] [Related]

  • 13. Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN/NAD consumers mediated by Twist2.
    Hasegawa K, Sakamaki Y, Tamaki M, Wakino S.
    Sci Rep; 2022 Aug 12; 12(1):13712. PubMed ID: 35962139
    [Abstract] [Full Text] [Related]

  • 14. An Fgr kinase inhibitor attenuates sepsis-associated encephalopathy by ameliorating mitochondrial dysfunction, oxidative stress, and neuroinflammation via the SIRT1/PGC-1α signaling pathway.
    Liu Y, Yang H, Luo N, Fu Y, Qiu F, Pan Z, Li X, Jian W, Yang X, Xue Q, Luo Y, Yu B, Liu Z.
    J Transl Med; 2023 Jul 20; 21(1):486. PubMed ID: 37475042
    [Abstract] [Full Text] [Related]

  • 15. NMN Alleviates NP-Induced Learning and Memory Impairment Through SIRT1 Pathway in PC-12 Cell.
    Li Z, Liu H, Han W, Zhu S, Liu C.
    Mol Neurobiol; 2023 May 20; 60(5):2871-2883. PubMed ID: 36745337
    [Abstract] [Full Text] [Related]

  • 16. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
    Wang X, Hu X, Yang Y, Takata T, Sakurai T.
    Brain Res; 2016 Jul 15; 1643():1-9. PubMed ID: 27130898
    [Abstract] [Full Text] [Related]

  • 17. Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.
    Park JH, Long A, Owens K, Kristian T.
    Neurobiol Dis; 2016 Nov 15; 95():102-10. PubMed ID: 27425894
    [Abstract] [Full Text] [Related]

  • 18. Nicotinamide mononucleotide (NMN) ameliorated Nonylphenol-induced learning and memory impairment in rats via the central 5-HT system and the NAD+/SIRT1/MAO-A pathway.
    Huang H, Shi J, Li Z, Rang Y, Li W, Xiao X, Chen C, Liu C.
    Food Chem Toxicol; 2023 Aug 15; 178():113878. PubMed ID: 37295765
    [Abstract] [Full Text] [Related]

  • 19. Nicotinamide Mononucleotide Attenuates LPS-Induced Acute Lung Injury With Anti-Inflammatory, Anti-Oxidative and Anti-Apoptotic Effects.
    Tian Y, Zhu CL, Li P, Li HR, Liu Q, Deng XM, Wang JF.
    J Surg Res; 2023 Mar 15; 283():9-18. PubMed ID: 36347171
    [Abstract] [Full Text] [Related]

  • 20. Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects.
    Yamane T, Imai M, Bamba T, Uchiyama S.
    Clin Nutr ESPEN; 2023 Aug 15; 56():83-86. PubMed ID: 37344088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.